Comparison Overview

Xiros

VS

Stryker

Xiros

Springfield House, Leeds, West Yorkshire, LS19 7UE, GB
Last Update: 2025-05-06 (UTC)
View Profile
Between 750 and 799
http://www.xiros.co.uk

Xiros develops, manufactures, and markets innovative orthopaedic devices and textile implants under our brand Xiros (previously Xiros Surgical and Neoligaments) and provides extensive expertise in research, development, design, manufacture, and marketing to others in the medical field. Working in collaboration with healthcare professionals, medical device companies and academic institutions, we provide various routes to market for inventions in the orthopaedic and sports medicine fields. First winning the Queen’s Award for Enterprise in 2008, Xiros was delighted to achieve this prestigious accolade for a second time in 2016. We are proud to have held the esteemed Investors in People Standard since July 2000 and achieved Investors in People Gold Standard Accreditation in March 2016: an accomplishment which underlines the people-oriented values upon which our company is built. Xiros products and their indications are subject to regional variations. To confirm availability in your region/country please contact [email protected]

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 57
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Stryker

2825 Airview Boulevard, None, Kalamazoo, MI, US, 49002
Last Update: 2025-08-05 (UTC)
Between 800 and 849
http://www.stryker.com

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2023 Sales: $20.5 billion ● Industry: Medical Instruments & Supplies ● Employees: 52,000 worldwide ● 40 years of sales growth leading up to 2020 ● 44+ Manufacturing and R&D Locations Worldwide ● $1.4 billion spent on research and development in 2023 ● ~12,900 patents owned globally in 2023 ● Products sold in ~75 countries ● Fortune 500 Company ● 7 consecutive years as one of Fortune's World's Best Workplaces Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 47,772
Subsidiaries: 39
12-month incidents
0
Known data breaches
1
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/xiros.jpeg
Xiros
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/stryker.jpeg
Stryker
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Xiros
100%
Compliance Rate
0/4 Standards Verified
Stryker
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Xiros in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Stryker in 2025.

Incident History — Xiros (X = Date, Y = Severity)

Xiros cyber incidents detection timeline including parent company and subsidiaries

Incident History — Stryker (X = Date, Y = Severity)

Stryker cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/xiros.jpeg
Xiros
Incidents

No Incident

https://images.rankiteo.com/companyimages/stryker.jpeg
Stryker
Incidents

Date Detected: 5/2024
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

FAQ

Stryker company demonstrates a stronger AI Cybersecurity Score compared to Xiros company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Stryker company has historically faced a number of disclosed cyber incidents, whereas Xiros company has not reported any.

In the current year, Stryker company and Xiros company have not reported any cyber incidents.

Neither Stryker company nor Xiros company has reported experiencing a ransomware attack publicly.

Stryker company has disclosed at least one data breach, while Xiros company has not reported such incidents publicly.

Neither Stryker company nor Xiros company has reported experiencing targeted cyberattacks publicly.

Neither Xiros company nor Stryker company has reported experiencing or disclosing vulnerabilities publicly.

Neither Xiros nor Stryker holds any compliance certifications.

Neither company holds any compliance certifications.

Stryker company has more subsidiaries worldwide compared to Xiros company.

Stryker company employs more people globally than Xiros company, reflecting its scale as a Medical Equipment Manufacturing.

Neither Xiros nor Stryker holds SOC 2 Type 1 certification.

Neither Xiros nor Stryker holds SOC 2 Type 2 certification.

Neither Xiros nor Stryker holds ISO 27001 certification.

Neither Xiros nor Stryker holds PCI DSS certification.

Neither Xiros nor Stryker holds HIPAA certification.

Neither Xiros nor Stryker holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

The Bold Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘percentage’ parameter in all versions up to, and including, 5.4.5 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Published
Date
2025-10-23
Updated
Date
2025-10-23
Risk Information
cvss3
Base: 6.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
References
Description

The ComboServlet in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions does not limit the number or size of the files it will combine, which allows remote attackers to create very large responses that lead to a denial of service attack via the URL query string.

Published
Date
2025-10-23
Updated
Date
2025-10-23
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary directories on the target machine.

Published
Date
2025-10-23
Updated
Date
2025-10-23
Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and create arbitrary directories on the target machine.

Published
Date
2025-10-23
Updated
Date
2025-10-23
Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary files on the target machine.

Published
Date
2025-10-23
Updated
Date
2025-10-23
Risk Information
cvss3
Base: 7.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:H
cvss4
Base: 8.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:H/SC:N/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References